Enovix Corporation (NASDAQ:ENVX) Given Consensus Rating of “Hold” by Brokerages

Enovix Corporation (NASDAQ:ENVXGet Free Report) has earned a consensus rating of “Hold” from the ten research firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $12.50.

A number of research firms recently weighed in on ENVX. TD Cowen decreased their target price on Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, July 24th. JPMorgan Chase & Co. cut Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Oppenheimer reduced their price objective on Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a research report on Thursday, May 14th. Benchmark decreased their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Finally, Craig Hallum lowered their price objective on Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th.

Get Our Latest Analysis on ENVX

Enovix Price Performance

Shares of Enovix stock opened at $3.68 on Thursday. The company has a debt-to-equity ratio of 2.14, a current ratio of 10.97 and a quick ratio of 10.65. The company has a market cap of $802.79 million, a PE ratio of -4.43 and a beta of 2.26. The firm has a fifty day moving average price of $6.09 and a two-hundred day moving average price of $6.14. Enovix has a fifty-two week low of $3.67 and a fifty-two week high of $14.33.

Enovix (NASDAQ:ENVXGet Free Report) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.01. The company had revenue of $7.60 million for the quarter, compared to the consensus estimate of $6.95 million. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The business’s revenue was up 49.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.15) EPS. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Analysts expect that Enovix will post -0.79 EPS for the current year.

Institutional Investors Weigh In On Enovix

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in Enovix by 10.9% in the 4th quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock valued at $129,831,000 after buying an additional 1,747,145 shares during the period. Millennium Management LLC raised its stake in shares of Enovix by 1,038.9% in the 3rd quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock valued at $14,724,000 after buying an additional 1,347,200 shares in the last quarter. Two Sigma Investments LP lifted its holdings in shares of Enovix by 9,197.1% during the 3rd quarter. Two Sigma Investments LP now owns 1,200,997 shares of the company’s stock worth $11,974,000 after acquiring an additional 1,188,079 shares during the period. Barclays PLC lifted its holdings in shares of Enovix by 263.1% during the 4th quarter. Barclays PLC now owns 1,551,941 shares of the company’s stock worth $11,345,000 after acquiring an additional 1,124,480 shares during the period. Finally, Electron Capital Partners LLC boosted its position in shares of Enovix by 13.8% during the 3rd quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock valued at $80,143,000 after acquiring an additional 972,103 shares in the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

See Also

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.